Based on in vitro work with rat liver, we recently suggested that the peroxisomal fraction is most important for the oxidation of 3a,7a,12a-trihydroxy-5,8-cholestanoic acid (THCA) into cholic acid. The cerebro-hepato-renal syndrome of Zellweger is a fatal recessive autosomal disorder, the most characteristic histological feature of which is a virtual absence of peroxisomes in liver and kidneys. This disease offers a unique opportunity to evaluate the relative importance of peroxisomes in bile acid biosynthesis. A child with Zellweger syndrome was studied in the present work. In accordance with previous work, there was a considerable accumulation of THCA, 3a,7a,12a,24-tetrahydroxy-5,6-cholestanoic acid (24-OH-THCA), 3a,7a,12a-trihydroxy-27-carboxymethyl-5#6-cholestan-26-oic acid (C2-dicarboxylic acid), and 3a,7a-dihydroxy-5#-cholestanoic acid in serum. In addition, a tetrahydroxylated 51e-cholestanoic acid with all the hydroxyl groups in the steroid nucleus was found.
Introduction
The cerebro-hepato-renal syndrome of Zellweger is an autosomal recessive disorder that is fatal within the first year of life (1) . The virtual absence of peroxisomes in liver and kidney has been described as the most consistent histologic finding (2) .
Increased amounts of C27-bile acid intermediates have been detected in bile, serum, and urine of the patients (3) (4) (5) (6) . These intermediates include 3a,7a,dihydroxy-5(3-cholestan-26-oic acid (DHCA),' 3a,7a, 1 2a-trihydroxy-5/3-cholestan-26-oic acid (THCA), and 3a,7a, 12a,24-tetrahydroxy-5f3-cholestan-26-oic acid (24-OH-THCA) (4) (5) (6) . The accumulation of bile acid precursors with a partially oxidized side chain has been attributed to a mitochondrial defect in the cleavage of the steroid side chain (4, 6) .
According to current concepts, the degradation of the steroid side chain in the biosynthesis of cholic acid starts with a mitochondrial 26-hydroxylation and subsequent oxidation to THCA (for review see reference 7). The further conversion seems to involve 24-OH-THCA and 3a,7a, 12a-trihydroxy-24-on-5,B-cholestanoic acid as intermediates, and propionic acid is cleaved off in the final step. An alternative pathway has been proposed involving microsomal 25-and 24S-hydroxylation of 5#-cholestane-3a,7a,12a-triol. Subsequent oxidation in this pathway yields 3a,7a,12a,25-tetrahydroxy-5,3-cholestan-24-one which is cleaved by cytosolic enzymes to cholic acid and acetone (8) .
Accumulation of THCA in patients with Zellweger syndrome would lend support to the contention that the major pathway in cholic acid formation involves 26-hydroxylation and intermediate formation of THCA.
We have recently shown that in rat liver the formation of cholic acid from THCA is most efficiently carried out by the peroxisomal fraction (9, 10). 1 . Abbreviations used in this paper: DHCA, 3a,7a-dihydroxy-5,3-cholestan-26-oic acid; GC-MS, gas chromatography-mass spectrometry; HPLC, high pressure liquid chromatography; 24-OH-THCA, 3a,7a, 12a,24-tetrahydroxy-5,B-cholestan-26-oic acid; THCA, 3a,7a, 12a-trihydroxy-5fl-cholestan-26-oic acid; C29-dicarboxylic acid, 3a,7a,12a-trihydroxy-27-carboxymethyl-5#-cholestan-26-oic acid.
Zellweger syndrome appears to offer a unique opportunity to evaluate the importance of liver peroxisomes in bile acid formation. In addition, the degree of conversion of different bile acid intermediates into THCA in such patients may give information with respect to the relative importance of the two alternative pathways described for biosynthesis of cholic acid in man.
We here report a study on the conversion in vivo of 5(tcholestane-3a,7a,12a-triol and THCA into cholic acid in a patient with Zellweger syndrome. No peroxisomes could be found in the liver of this patient. The limited capacity for conversion of these precursors into cholic acid in vivo suggests that the metabolic defect resides at the peroxisomal level and that under normal conditions the major part of cholic acid formation proceeds via the peroxisomal pathway.
Methods
Clinical. The child was a fuilterm female of healthy nonconsanguineous parents. In mother's family several members had epilepsy. Muscular hypotonia prevailed from birth. She displayed a craniofacial dysmorphy characteristic of Zellweger syndrome (1) . There was pes equino varus and four finger line bilaterally. With time, hepatomegaly developed and convulsions appeared which increased in frequency and duration. She was treated with 5 mg/kg phenobarbital. This floppy infant died at 4-mo-old.
Cerebral computer tomography was normal while EEG was pathologic. The levels of alanine aminotransferase and aspartate aminotransferase were highest shortly after birth (aspartate aminotransferase 1,164 decreased, but were almost normal at the time of the in vivo study (60% [70-130%]). Serum cholesterol was 6.7 mmol/ml (2.2-4.2 mmol/ ml) while triglycerides were in the normal range. No pipecolate was detectable in urine. Cultured fibroblasts contained high amounts of saturated long chain fatty acids (11). At autopsy the liver was found enlarged with normal extrahepatic bile ducts. The liver surface was uneven, and microscopically marked interlobular septae and large periportal areas were seen. The lobular architecture was intact and cirrhosis was not detected. By electron microscopy the cellular architecture appeared normal with increased amounts of glycogen. Normal peroxisomal structures could not be recognized. In the central nervous system neuronal migration arrest typical for Zellweger syndrome (12) was observed.
The ethical aspects of the present study were approved by the ethical board of the Norwegian Council for Science and the Humanities.
Preparation of labeled steroids. 7f3-3H-5ft-cholestane-3a,7a,l2a-triol (7 Ci/mol) and 7#_3PH-THCA (200 Ci/mol) were prepared as described (13, 14) . Separation on high pressure liquid chromatography (HPLC) of the latter compound (10) showed that it contained 28% of the 25R and 72% of the 25S isomer. 24-"C-Cholic acid (50 Ci/mol) was from Amersham International plc, Amersham, England. The compounds were purified by HPLC (see below) before use.
In vivo administration oflabeled steroids and collection ofbile and serum samples. The tritium-labeled triol (13.4 X 10 dpm) and the '"C-labeled cholic acid (1.5 X 106 dpm) were dissolved in 0. 1 mo later the patient received 3H-labeled THCA, 13 X 106 dpm, and "4C-labeled cholic acid, 1.5 X 106 dpm, dissolved in 180 ,ul ethanol, mixed into the milk, and given through a gastric tube. Blood samples were collected 6, 12, and 24 h after the meal and duodenal content was aspirated 11 h later.
Extraction, chromatography, and analytical procedures. The serum samples (0.25 ml) were hydrolyzed and extracted as described previously (I5, 16) . In this extraction procedure, most but not all cholesterol is removed. To the serum samples used for assay by isotope dilutionmass spectrometry, deuterium-labeled cholic acid, chenodeoxycholic acid, and deoxycholic acid were added before hydrolysis (15, 16) . The methyl ester trimethylsilyl ether derivatives were prepared before combined gas chromatography-mass spectrometry (I5, 16 ). An LKB 9000 instrument equipped with a multiple ion detector and an 1.5% SE-30 column was used (15, 16) . The amount of cholic acid was measured by use of the ions at mle 623 and 628 (corresponding to the M-15 ion in the mass spectrum of derivative of unlabeled and 2H5-labeled cholic acid, respectively [16] (15, 16) and analyzed by combined gas chromatography-mass spectrometry (GC-MS) as described above. For identification of the different steroids, characteristic ions were followed by multiple ion detection. In a few cases in which sufficient amounts of material could be obtained, a full mass spectrum was recorded (refer above and to Results).
Assumptions and calculations. It was assumed that no loss of 3H occurred during the metabolism of 7ft-3H-labeled precursors of cholic acid. The justification of this assumption is supported by a recent study with a mixture of 70-3H-and 24-"C-labeled cholic acid. There was only a negligible loss of 3H from the cholic acid during the enterohepatic circulation in man (Bjorkhem, I., K. Einarsson, and K. Nilsell, unpublished observation).
The conversion of the 3H-labeled triol and the 3H-labeled THCA into cholic acid was based on the ratio between 3H and 14C in the mixture injected into the patient, which was compared with the ratio between 3H and 14C in the cholic acid isolated. It is then assumed that 100% conversion of the 3H-labeled precursor should yield cholic acid with a ratio 3H/"4C, identical with that in the material injected. The validity of this experimental approach is evident from results of a similar study by Hanson et al. (17, 18) . It was reported that after intravenous administration of 3H-THCA or 3H-50-cholestane3a,7a,12a,26-tetrol together with '4C-cholic acid to normal subjects, the 3H-cholic acid specific activity decay curves were within 81-91% of the '4C-cholic acid specific activity decay curves. Furthermore, in an in vivo study on another Zellweger patient that was performed after the completion of this work, we obtained a larger number of bile samples and were thus able to compare our method with that used by Hanson and Williams (17) . The percent conversion calculated by our method was 20% higher than calculated by the method of Hanson and Williams (17) . From the decay of the specific radioactivity of '4C in cholic acid in bile isolated after the intravenous administration of '4C-cholic acid, the pool size and half life of cholic acid was determined according to the Lindstedt technique (19) .
Results
Serum bile acids. Fig. 1 A shows multiple ion recordings of the ion at m/e 253 (corresponding to the trihydroxycoprostanoic nucleus) and at m/e 255 (corresponding to the dihydroxycoprostanoic nucleus) obtained in analysis of a hydrolyzed and derivatized sample of a serum extract from the patient. From the pattern obtained, it is evident that there was a predominance of trihydroxy bile acids. In the recording of the ion at m/e 253, peaks occurred with retention times identical to derivatives of cholic acid, THCA, and 3a,7a,l2a,24-tetrahydroxy-5,3-cholestan-26-oic acid (24-OH-THCA). In addition there was a prominent peak with a retention time typical for that of the 3a,7a, 12a-trihydroxy-27-carboxy-methyl-5(3-cholestan-26-oic acid (C29-dicarboxylic acid) described by Parmentier et al. (5) . Evidence has been given that the structure of this acid is 3a,7a, 12a -trihydroxy -27 -carboxymethyl -5(3 -cholestan -26 -oic acid (20) . In addition, a peak occurred with a retention time slightly longer than that of 24-OH-THCA in the recording of the ion at m/e 253. The identity of this compound could never be established.
The peak occurring in the tracing of mle 255, just in front of the chenodeoxycholic acid peak, corresponds to cholesterol. The trimethylsilyl ether of methyl chenodeoxycholic acid partly cochromatographed with deoxycholic acid under the conditions employed. Under slightly different chromatographic conditions it was shown that there was no derivative of deoxycholic acid. There were significant amounts of DHCA but only traces of 24-OH-DfiCA. In a separate recording of the ion at m/e 372 (corresponding to the M-90 ion in the mass spectrum of derivative of lithocholic acid) it was shown that there were only traces of lithocholic acid.
In view of the relatively small amounts of serum available, it was not possible to record full mass spectra. The identity of cholic acid was established, however, by selected recording of the ions at mle 623 (M-15) and m/e 368 (M-3 X 90). The identity of chenodeoxycholic acid was also confirmed by the tracing of the ion at mle 370 (M-2 X 90). The identity of THCA was confirmed by the tracing of the ions at m/e 500 and mle 410 (M-2 X 90 and M-3 X 90 in the mass spectrum of derivative of THCA), and that of 24-OH-THCA by the ions at m/e 588 and mle 498 (M-2 X 90 and M-3 X 90 in the mass spectrum of derivative of 24-OH-THCA). The identity of the C29-dicarboxylic acid was established by use of the ions at mle 482 (M-3 X 90) and mle 737 (M-15) (5).
The concentrations of cholic acid, chenodeoxycholic acid, and THCA were determined by isotope dilution-mass spectrometry using 2H5-labeled cholic acid and chenodeoxycholic acid as internal standards (16) . The approximate concentration of 24-OH-THCA and C29-dicarboxylic acid was determined from the tracing at mle 253. It was assumed that the relative intensity of the ion at m/e 253 was similar in the mass spectrum of THCA, 24-OH-THCA, and C29-dicarboxylic acid.
The results of these determinations of serum samples taken at different occasions are summarized in Table I . For the reasons of comparison, a selected ion monitoring analysis of a serum extract from a healthy infant of the same age is shown in Fig. 1 B. As expected, only peaks corresponding to cholic acid and chenodeoxycholic acid were seen. When compared with normal fasting reference values (21, 22) , the serum concentrations of cholic acid and chenodeoxycholic acid could be regarded as normal. During the further progression of the disease, both chenodeoxycholic and cholic acid remained within normal limits (Table I) . Deoxycholic acid was not detected in most samples. The precursors of the primary bile acids and the C29-dicarboxylic acid that were measured in high concentrations are normally not detected in infant serum.
Biliary bile acids. Using the same isotope dilution technique as in the analyses of the serum bile acids, it was shown that the composition of bile acids in a sample of bile from the patient at the age of 10 wk was the following: cholic acid 42%, chenodeoxycholic acid 53%, THCA 4%, 24-OH-THCA 1%, and C29-dicarboxylic acid 0%. Normally, only cholic acid and chenodeoxycholic acid can be expected to occur in the bile of an infant of this age, and the relative amount of cholic acid can be expected to vary between 20 and 60% (23, Bjorkhem, I., unpublished observation).
Conversion in vivo of 7,3-3H-S3-cholestane-3a, 7a, 12a-triol into bile acids. After administration in vivo of 3H-labeled 513-cholestane-3a,7a,122a-triol and '4C-cholic acid, bile, serum, and urine samples were hydrolyzed and extracted as described in Methods. The ratio of 3H to 14C activity of the infused material (in dpm) was 8.9. In the serum extracts this ratio was 13.3 in the 24-h sample and 15.8 in the 48-h sample. In bile extracts this ratio fell from 3.8 to 2.9.
The bile extracts were analyzed by HPLC, and the chromatogram of the extract of the sample collected 3 h after the infusion is shown in Fig. 2 . Two major peaks of radioactivity were detected. The more polar of these, that eluted at 18 ml, contained both 3H and 14C activity. The retention time was identical to that of cholic acid. The presence of cholic acid in this material was confirmed by GC-MS using selected ion monitoring of the ions at m/e 253, mle 368, and mle 623.
The largest and most nonpolar splitted peak that eluted from 44 to 53 ml had the same retention time as 25R and 25S THCA. Only tritium activity was detected in this peak. The presence of THCA in this material was confirmed by GC-MS, using the ion at m/e 253, m/e 410, and m/e 500. Several smaller tritium-containing peaks were also detected in the chromatograms. The peak that eluted at 14 ml contained material identified by GC-MS as a derivative of THCA with a hydroxyl group in the steroid nucleus. Selected ion monitoring showed the presence of an ion at m/e 251 (loss of four trimethylsilyl groups from the steroid nucleus) as well as presence of ions at m/e 498 (M-3 X 90) and m/e 588 (M-2 X 90). (For tentative identification see below.) A small peak that eluted at 20 ml contained material that was identified as 24-OH-THCA using the ions at 253, m/e 498 and mle 588. The material corresponding to the small peak that eluted at 33-34 ml was never identified. Recovery from the column was essentially complete in this chromatographic system and no unmetabolized 3H-5f3-cholestane-3a,7a,12a-triol was detected.
The chromatogram in Fig. 2 showed that 3H-THCA accounted for 65% of total recovered activity in the 3-h bile sample. This relative activity declined almost linearly to 35% after 48 h. This finding reflected rapid conversion of 3H-triol into 3H-THCA and a high degree of retention of the formed 3H-THCA.
After 24 and 48 h, the 3H/4'C ratio in cholic acid was 15% of the infused material (Fig. 3) . The value of 20% found after 35 h was based on very low activity (-200 dpm for tritium) and might therefore be uncertain. Fig. 2 . The ratio of 3H/ 14C in the cholic acid peak fraction (elution volume 18 ml) has been expressed as percentage of the 3H/'4C ratio of the infused 3H-triol and '4C-cholic acid tritium activity.
Fig. 4 shows the specific radioactivity decay curves of 14C-cholic acid, 3H-cholic acid, and 3H-THCA. From the specific radioactivity decay curve of '4C-cholic acid, it could be calculated that the pool size of cholic acid in the patient was only 24 mg/M2. The synthetic rate of cholic acid (19, 24) was 9 mg/m2/d. The specific radioactivity of 3H in cholic acid increased between 3 and 6 h and then decreased. Due to the small amounts of radioactivity, the accuracy in the latter measurement may be low, and no specific information can therefore be obtained from the decay of 3H specific radioactivity between 6 and 24 h. The specific radioactivity of 3H-THCA was about one magnitude higher than that of 3H-cholic acid and remained constant between 3 and 24 h. The most likely explanation of this fairly constant specific activity is a continuous formation of 3H-THCA from an intrahepatic pool of 3H-triol.
The serum samples drawn 24 and 48 h after the infusion of 3H-5,3-cholestane-3a,7a,12a-triol and 14C-cholic acid were hydrolyzed and extracted as described in Methods. The extracts were separated on HPLC and the material in the tritiumcontaining peaks was analyzed by GC-MS as above. The HPLC profile of the extract of the serum sample taken 24 h after the infusion is shown in Fig. 5 Hydrolysis, extraction, and HPLC procedures are given in Methods.
The most polar peak with elution volume 5 ml was not identified.
Other peaks correspond to the following: 3a,6a,7a,12a-tetrahydroxy-5#-cholestanoic acid (tentatively identified, see text), 12 ml, cholic acid, 15 ml, 24-OH-THCA, 19 ml, 25R and 25S-THCA, 35 and 37 ml, respectively. C29-dicarboxylic acid was identified in the fraction that eluted at 20 ml. For additional information see text.
cation, but the presence of a trihydroxy cholestane nucleus was confirmed by selected ion monitoring of the ion at m/e 253. The tritium activity corresponding to THCA amounted to 35 and 26% of the total activity recovered after 24 and 48 h, respectively. In the overnight urine sample collected 15 h after the infusion the 3H activity was 5,500 dpm/ml. After extraction and chromatography, this activity could entirely be accounted for as THCA or more polar products. In particular, 55% of the activity was recovered in fractions corresponding to tetrahydroxylated 5fl-cholestanoic acid with all hydroxyl groups in the steroid nucleus (see below).
Conversion in vivo of 7,3-3H-THCA into bile acids. After administration per os of 3H-THCA and '4C-labeled cholic acid, bile and serum samples were hydrolyzed, extracted, and analyzed by HPLC as described in Methods. The material in the tritium-containing peaks was identified by GC-MS as described above. The HPLC profile of the extract of the bile collected 11 h after administration ofthe radioactive compounds is shown in Fig. 6 . About 50% of the tritium activity was recovered in the peak corresponding to THCA (elution volume 39-48 ml), and most of the remaining was recovered in the cholic acid fraction. The material in the small peak that eluted in front of cholic acid (elution volume i 1-12 ml) was not identified, but corresponded to the similar peak observed in the chromatogram of the serum extract (see below). The ratio of 3H to 14C in the cholic acid peak was 7.7% of that in the radioactive mixture given per orally. This shows that after 11 h the formation of cholic acid from THCA is considerably reduced compared with what is found when 3H-THCA is administered to normal subjects (17) .
In the chromatogram of the extract of the pooled serum samples (Fig. 7) , a peak corresponding to THCA was identified as above (elution volume 46-53 ml). The major tritiumcontaining peak that eluted in front of cholic acid (elution Elution volume (ml) Figure 6 . Reversed phase high pressure liquid chromatogram of duodenal bile extract 11 h after the administration of 3H-THCA per os. Hydrolysis, extraction, and HPLC procedures are given in Methods. The main radioactive peaks correspond to the following: 3a,6a,7a,12a-tetrahydroxy-5,-cholestanoic acid (tentatively identified, see text), 11-12 ml, cholic acid, 15 ml, 24-OH-THCA, 21 
Discussion
Increased amounts in serum and bile of C27-steroids with a partially oxidized side chain is a characteristic finding in Zellweger syndrome (4) (5) (6) . This was confirmed in the present work ( Fig. 1 and Table I ). A defective mitochondrial side chain cleavage has been suggested as an explanation for this accumulation (4, 6) . Abnormal structure and function of liver mitochondria have been described in Zellweger syndrome (2), but such a finding does not seem to be obligate (25) . More remarkable, however, is that no peroxisomes can be recognized in liver and kidneys of the patients (2), and the possibility has been discussed that the mitochondrial changes are secondary to the lack of peroxisomes (25, 26) . Recently, we could demonstrate that in the rat liver the peroxisomal fraction was by far the most active in catalyzing conversion of THCA into cholic acid (9, 10) , and the same seems to be the case in human liver (unpublished experiments), In view of this, it seems likely that the accumulation of the C27-steroid bile acid precursors, in particular of THCA in Zellweger syndrome, is due to a reduced capacity for peroxisomal 13-oxidation of the steroid side chain.
The results of our in vivo experiments showed that radioactivity given as 5ft-cholestane-3a,7a, 12a-triol rapidly appeared in more polar products with partially oxidized C27-steroid side chain, mainly as THCA (Fig. 2) . This shows that the mitochondrial 26-hydroxylation is functioning in Zellweger syndrome and supports the previous suggestion that the metabolic defect is localized at the final side chain cleavage reaction (4) . In addition, the rapid conversion of 513-cholestane-3a,7a,12a-triol into THCA seems to exclude the possibility that microsomal 25-and 24S-hydroxylation of 513-cholestane-3a,7a, 12a-triol is an important pathway for formation of cholic acid in man (8, 27 (17, 18, (30) (31) (32) . When 3H-51-cholestane-3a,7a,12a-triol was given to bile fistula patients, -75% was converted to cholic acid (31) . The peak specific activity in cholic acid occurred already after 30 min and the tritium activity corresponding to the precursor was completely eliminated after 13 h (31). Similarly, when 3H-THCA was administered intravenously to either normal subjects (17) or to bile fistula patients (32) , there was a rapid and nearly complete (81-97%) conversion into cholic acid. These results contrast with our finding of a maximal conversion of 513-cholestane 3a,7a, 12a-triol to cholic acid of - 15-20% (Fig. 3) . 11 h after administration, the degree of conversion to cholic acid was only 9% for 3H-5fl-cholestane3a,7a, 12a-triol and 8% for 3H-THCA (Figs. 3 and 6 ). In the evaluation of these results it should be kept in mind that the THCA experiment was performed only a few weeks before the patient died.
,8-Oxidation of the steroid side chain is not a limiting step under normal conditions, and there is likely to be a considerable overcapacity of enzyme activity in the peroxisomes. The low conversion of 3H-THCA into cholic acid observed here may be due to residual peroxisomal enzyme activity, or to the presence of alternative pathways to cholic acid bypassing the peroxisomal system. The similar rate of conversion of labeled 513-cholestane-3a,7a,12a-triol and of THCA into cholic acid during the first 11 h (refer above) makes it unlikely that the 25-hydroxylase pathway (see Introduction) plays an important role in the Zellweger syndrome as has been suggested (4). If alternative pathways exist from the triol, it is therefore more likely that these involve metabolic modifications of THCA.
The very low specific radioactivity of 3H in the cholic acid as compared with that of 3H-THCA may suggest that part of the cholic acid in the patient had been formed by an unknown pathway bypassing both 513-cholestane-3a,7a,12a-triol and THCA. More likely, the low ratio of specific activities may be explained by a very slow influx of tritium from THCA into a much larger cholic acid pool in bile (refer to Results). Differences in slopes of the decay curves could tell if alternative pathways are involved. Such information would require a longer collection period and more data points than we were able to obtain in Fig. 4 . Also, Hanson et al. (33) , who studied the metabolism of labeled THCA in two siblings with cholestasis due to intrahepatic bile duct anomalies, reported similar findings as ours. Also, in that case, there was a higher specific radioactivity in THCA than in cholic acid isolated from urine. The differences were, however, less marked than in the present study.
The pool size of cholic acid (24 mg/m2) was drastically reduced in our patient. Watkins et al. (23) reported a pool size of -300 mg/m2 for newborn healthy full-term infants (24) and _90 mg/M2 for premature infants. The daily production rate of cholic acid corresponds to -'/I0 of that formed in normal newborns (24) , which indicates that the deficient conversion of THCA to cholic acid is not compensated for by alternative pathways.
A main product in serum and urine from both 513-cholestane-3a,7a,12a-triol and THCA was identified as a tetrahydroxylated 5f3-cholestanoic acid with all hydroxyl groups in the steroid nucleus. 11 and 6a-hydroxylated cholic acid has been identified in human neonatal urine (34) and 213-and 6a-hydroxylated cholic acid has been found in duodenal aspirates from neonates with high intestinal obstruction (35) . It thus appears likely that the tetrahydroxylated THCA could be hydroxylated in 113, 2,B, or 6a position. Since a characteristic ion at mle 217 or m/e 243 was lacking, the first two possibilities may be excluded. We are left with the possibility that the structure corresponds to 3a,6a,7a,12a-tetrahydroxy-513-cholestanoic acid, but further work is needed to establish this. Since this compound is relatively polar, it may represent an important route for urinary excretion of accumulated THCA. The retention time of the hydroxylated THCA on gas chromatography is very similar to that of 24-OH-THCA, and by mass fragmentography they share several fragments. This may have caused overestimation of the amount of accumulated 24-OH-THCA in Zellweger syndrome in a previous report (4) .
After injection of 5#-cholestane-3a,7a,12a-triol, and after administration of THCA per os, we could detect only small amounts of tritium activity in the peak corresponding to 24-OH-THCA (Figs. 5 and 7) . Accumulation of 24-OH-THCA has been taken as evidence for a metabolic block in the conversion of 24-OH-THCA into cholic acid in mitochondria (4) . Another possibility is that the 24-OH-THCA identified may be a product of hydroxylation in the endoplasmic reticulum. Determination of the stereoisomeric structure of the compound may differentiate between these possibilities.
It should be emphasized that our patient was treated with phenobarbital, and it cannot be excluded that the hydroxylase activity observed here in part may have been induced by the treatment. Very recently, however, we were able to analyze serum from another infant with the Zellweger syndrome that had never been treated with phenobarbital. The pattern of bile acids in serum from that infant was almost identical to that obtained here.
After administration of the cholic acid precursors, we could detect only small amounts of radioactivity that corresponded to the C29-dicarboxylic acid. This appeared surprising in view of the high concentration of this compound in serum. The explanation may be that this metabolite is formed very slowly by chain elongation of THCA. Since there is very little excretion of this compound in bile and urine (5) it accumulates in plasma. The chain elongation of THCA may be analogous to the elongation of long-chain fatty acids in fibroblasts cultured from skin biopsies from patients with Zellweger syndrome (36) . Chain shortening of very long-chain fatty acids is one important function of peroxisomes (37) . Accumulation of C29-dicarboxylic acid (5) and very long-chain fatty acids in Zellweger syndrome (36) may thus both be the expression of compensating mechanisms to restricted peroxisomal metabolic processes.
Adrenal leucodystrophy i's another clinical entity with accumulation of very long-chain fatty acids and depletion of peroxisomes (11, 36). Thus, both this disease and Zellweger syndrome probably represent a new class of peroxisomal diseases with different clinical expressions.
We conclude from the present findings that liver peroxisomes are essential in the normal formation of cholic acid from THCA. In Zellweger syndrome, there is a defective conversion of THCA to cholic acid (Fig. 8) , and as a consequence the accumulated THCA is either excreted as such or transformed to other metabolites by hydroxylation or by chain elongation.
